Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesRadiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study
Journal of Neuro-Oncology, 08/27/09
Balducci M et al. – At a median follow–up of 66 months (range 3–96), median progression–free survival (PFS) was 8 months, with a 1– and 2–year PFS of 46.7 and 28.7%, respectively; median overall survival (OS) time was 21 months, with a 1– and 2–year OS of 69.2 and 42.3%, respectively. In the authors' experience, TMZ proved to be effective even when given only during the first and the last week of radiotherapy, with lower hematological toxicity.
Related Articles
Treatment of recurrent high-grade gliomas
Current Opinion in Neurology, 11/12/09
Relevance Score: 82%
Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT
Journal of Neuro-Oncology, 10/30/09
Relevance Score: 82%
A Phase II Study of Cisplatin and Temozolomide in Heavily Pre-treated Patients with Temozolomide-refractory High-grade Malignant Glioma
Anticancer Research, 11/13/09
Relevance Score: 81%
Diagnostic Value of Proton Magnetic Resonance Spectroscopy in the Noninvasive Grading of Solid Gliomas: Comparison of Maximum and Mean Choline Values
Neurosurgery, 10/26/09
Relevance Score: 81%
Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas
Neuro-Oncology, 10/05/09
Relevance Score: 81%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Cancer Research, 12/20/09
Acyl-CoA Synthetase VL3 Knockdown Inhibits Human Glioma Cell Proliferation and Tumorigenicity
Cancer Research, 12/20/09
Mutant Metabolic Enzymes Are at the Origin of Gliomas
Cancer Research, 12/20/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
Journal of Clinical Oncology, 12/20/09
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/20/09
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/20/09
Sponsor
Article Search
Sponsor
Sponsor